E-LIB Suche - Ergebnisse für: Choe, Hannah K.

1

CRISPR/Cas9 deletion of MIR155HG in human T cells reduces i..:

Neidemire-Colley, Lotus ; Khanal, Shrijan ; Braunreiter, Kara M....
Blood Advances. 8 (2024) 4 - p. 947-958 , 2024

Link: https://doi.org/10.1182/..

2

Flares of acute graft-versus-host disease: a Mount Sinai Ac..:

Akahoshi, Yu ; Spyrou, Nikolaos ; Hoepting, Matthias...
Blood Advances. 8 (2024) 8 - p. 2047-2057 , 2024

Link: https://doi.org/10.1182/..

3

Dupilumab for refractory sclerotic‐type cutaneous graft‐ver..:

Mital, Rohan ; Penza, Sam L. ; Choe, Hannah K...
Journal of the European Academy of Dermatology and Venereology. 37 (2023) 11 - p. , 2023

Link: https://doi.org/10.1111/..

4

Incidence, clinical presentation, risk factors, outcomes, a..:

Akahoshi, Yu ; Spyrou, Nikolaos ; Hogan, William J....
Blood Advances. 7 (2023) 16 - p. 4479-4491 , 2023

Link: https://doi.org/10.1182/..

5

Disease progression, hospital readmissions, and clinical ou..:

Holtan, Shernan G. ; Yu, Jingbo ; Paranagama, Dilan...
Bone Marrow Transplantation. 57 (2022) 9 - p. 1399-1404 , 2022

Link: https://doi.org/10.1038/..

6

Correction to: Disease progression, treatments, hospitaliza..:

Holtan, Shernan G. ; Yu, Jingbo ; Choe, Hannah K....
Bone Marrow Transplantation. 58 (2022) 2 - p. 237-237 , 2022

Link: https://doi.org/10.1038/..

7

Disease progression, treatments, hospitalization, and clini..:

Holtan, Shernan G. ; Yu, Jingbo ; Choe, Hannah K....
Bone Marrow Transplantation. 57 (2022) 10 - p. 1581-1585 , 2022

Link: https://doi.org/10.1038/..

8

Inhibition of Bromodomain and Extra Terminal (BET) Domain A..:

Snyder, Katiri J. ; Choe, Hannah K. ; Gao, Yandi...
Frontiers in Oncology. 11 (2021) - p. , 2021

Link: https://doi.org/10.3389/..

9

Disease risk and GVHD biomarkers can stratify patients for ..:

Aziz, Mina D. ; Shah, Jay ; Kapoor, Urvi...
Leukemia. 34 (2020) 7 - p. 1898-1906 , 2020

Link: https://doi.org/10.1038/..

10

Clinical activity of axicabtagene ciloleucel in adult patie..:

Kittai, Adam S. ; Bond, David A. ; William, Basem...
Blood Advances. 4 (2020) 19 - p. 4648-4652 , 2020

Link: https://doi.org/10.1182/..

11

Biomarker-guided preemption of steroid-refractory graft-ver..:

Gergoudis, Stephanie C. ; DeFilipp, Zachariah ; Özbek, Umut...
Blood Advances. 4 (2020) 24 - p. 6098-6105 , 2020

Link: https://doi.org/10.1182/..

12

The MAGIC algorithm probability is a validated response bio..:

Srinagesh, Hrishikesh K. ; Özbek, Umut ; Kapoor, Urvi...
Blood Advances. 3 (2019) 23 - p. 4034-4042 , 2019

Link: https://doi.org/10.1182/..

13

Incidence, clinical presentation, risk factors, outcomes, a..:

Akahoshi, Yu ; Spyrou, Nikolaos ; Hogan, William J...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10440469/. , 2023

Link: http://www.ncbi.nlm.nih...

14

Haploidentical vs. sibling, unrelated, or cord blood hemato..:

Wieduwilt, Matthew J ; Metheny, Leland ; Zhang, Mei-Jie...
qt70v3q8pw. , 2022

Link: https://escholarship.org..

15

Haploidentical vs. sibling, unrelated, or cord blood hemato..:

Wieduwilt, Matthew J ; Metheny, Leland ; Zhang, Mei-Jie...
https://boris.unibe.ch/159598/. , 2022

Link: https://boris.unibe.ch/1..